Qualigen Therapeutics Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors
Stock Information for Qualigen Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.